SlideShare a Scribd company logo
Modeling 
the 
Ebola 
Outbreak 
in 
West 
Africa, 
2014 
Sept 
2nd 
Update 
Bryan 
Lewis 
PhD, 
MPH 
(blewis@vbi.vt.edu) 
Caitlin 
Rivers 
MPH, 
Eric 
Lofgren 
PhD, 
James 
Schli., 
Ka2e 
Dunphy, 
Stephen 
Eubank 
PhD, 
Madhav 
Marathe 
PhD, 
and 
Chris 
Barre. 
PhD 
Technical 
Report 
#14-­‐099 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on
Currently 
Used 
WHO 
Data 
Cases 
Deaths 
Guinea 
648 
430 
Liberia 
1378 
694 
Sierra 
Leone 
1026 
422 
Nigeria 
17 
6 
Total 
3069 
1563 
● Data 
reported 
by 
WHO 
on 
Aug 
29 
for 
cases 
as 
of 
Aug 
26 
● Sierra 
Leone 
case 
counts 
censored 
up 
to 
4/30/14. 
● Time 
series 
was 
filled 
in 
with 
missing 
dates, 
and 
case 
counts 
were 
interpolated. 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
2
Epi 
Notes 
• Case 
iden2fied 
in 
Senegal 
– Guinean 
student, 
sought 
care 
in 
Dakar, 
iden2fied 
and 
quaran2ned 
though 
did 
not 
report 
exposure 
to 
Ebola, 
thus 
HCWs 
were 
exposed. 
BBC 
• Liberian 
HCWs 
survival 
credited 
to 
Zmapp 
– Dr. 
Senga 
Omeonga 
and 
physician 
assistant 
Kynda 
Kobbah 
were 
discharged 
from 
a 
Liberian 
treatment 
center 
on 
Saturday 
ader 
recovering 
from 
the 
virus, 
according 
to 
the 
World 
Health 
Organiza2on. 
CNN 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
3
Epi 
Notes 
• Guinea 
riot 
in 
Nzerekore 
(2nd 
city) 
on 
Aug 
29 
– Market 
area 
“disinfected,” 
angry 
residents 
a.ack 
HCW 
and 
hospital, 
“Ebola 
is 
a 
lie” 
BBC 
• India 
quaran2nes 
6 
“high-­‐risk” 
Ebola 
suspects 
on 
Monday 
in 
New 
Delhi 
– Among 
181 
passengers 
who 
arrived 
in 
India 
from 
the 
affected 
western 
African 
countries 
HealthMap 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
4
Further 
evidence 
of 
endemic 
Ebola 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
5 
• 1985 
manuscript 
finds 
~13% 
sero-­‐prevalence 
of 
Ebola 
in 
remote 
Liberia 
– Paired 
control 
study: 
Half 
from 
epilepsy 
pa2ents 
and 
half 
from 
healthy 
volunteers 
– Geographic 
and 
social 
group 
sub-­‐analysis 
shows 
all 
affected 
~equally
Twi.er 
Tracking 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
6 
Most 
common 
images: 
Risk 
map, 
lab 
work 
(britain), 
joke 
cartoon, 
EBV 
rally
Liberia 
Forecasts 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
7
Liberia 
Forecasts 
rI: 
0.95 
rH: 
0.65 
rF: 
0.61 
R0 
total: 
2.22 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
8 
8/6 
– 
8/12 
8/13 
– 
8/19 
8/20 
– 
8/26 
8/27 
– 
9/02 
9/3 
– 
9/9 
9/10 
– 
9/16 
Actual 
163 
232 
296 
296 
-­‐-­‐ 
-­‐-­‐ 
Forecast 
133 
176 
234 
310 
410 
543 
Model 
Parameters 
'alpha':1/12, 
'beta_I':0.17950, 
'beta_H':0.062036, 
'beta_F':0.489256, 
'gamma_h':0.308899, 
'gamma_d':0.075121, 
'gamma_I':0.050000, 
'gamma_f':0.496443, 
'delta_1':.5, 
'delta_2':.5, 
'dx':0.510845
Liberia 
Vaccina2ons 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
9 
20% 
of 
popula2on 
Vaccinated 
on 
Nov 
1st 
and 
Jan 
1st 
Addi2onal 
Infec2ons 
Prevented 
(by 
April 
2015): 
Nov 
1st 
-­‐ 
~275k 
Jan 
1st 
-­‐ 
~225k
New 
model 
for 
Liberia 
• Due 
to 
con2nued 
underes2ma2on, 
have 
refit 
model 
– Small 
increases 
in 
betas 
change 
the 
fit 
compared 
to 
“stable” 
fit 
of 
last 
3 
weeks 
– May 
shid 
to 
this 
model 
for 
future 
forecasts 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
10
Sierra 
Leone 
Epi 
Details 
• asdfsdf 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
11 
By 
Sierra 
Leone 
MoH 
has 
1077 
cases 
(vs. 
1026 
as 
reported 
by 
WHO)
Sierra 
Leone 
Forecasts 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
12
Sierra 
Leone 
Forecasts 
rI:0.85 
rH:0.74 
rF:0.31 
R0 
total: 
1.90 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
13 
8/6 
– 
8/12 
8/13 
– 
8/19 
8/20 
– 
8/26 
8/27 
– 
9/02 
9/3 
– 
9/9 
9/10 
– 
9/16 
Actual 
143 
93 
100 
-­‐-­‐ 
-­‐-­‐ 
-­‐-­‐ 
Forecast 
135 
168 
209 
260 
324 
405 
Model 
Parameters 
'alpha':1/10 
'beta_I':0.164121 
'beta_H':0.048990 
'beta_F':.16 
'gamma_h':0.296 
'gamma_d':0.044827 
'gamma_I':0.055 
'gamma_f':0.25 
'delta_1':.55 
delta_2':.55 
'dx':0.58
Sierra 
Leone 
Vaccina2ons 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
14 
100k 
on 
Nov 
1st 
200k 
on 
Jan 
1st 
Addi2onal 
Infec2ons 
prevented 
(by 
April 
2015) 
Nov 
1st 
-­‐ 
~6k 
Jan 
1st 
-­‐ 
~7.5k
All 
Countries 
Forecasts 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
15 
rI:0.85 
rH:0.74 
rF:0.31 
Overal:1.90
All 
Countries 
Vaccina2ons 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
16 
100k 
on 
Nov 
1st 
200k 
on 
Jan 
1st 
Addi2onal 
Infec2ons 
prevented 
(by 
April 
2015) 
Nov 
1st 
-­‐ 
~3.2k 
Jan 
1st 
-­‐ 
~4.0k 
• Need 
more 
than 
just 
vaccine 
to 
interupt 
transmission
Extrac2ng 
the 
Guinea 
experience 
• Result: 
Not 
enough 
informa2on 
in 
early 
slight 
decrease 
to 
harvest 
meaningful 
impacts. 
– Model 
won’t 
fit 
well 
• Conclusion: 
Likely 
need 
to 
wait 
another 
week 
or 
so 
to 
assess 
impacts 
of 
recent 
new 
push 
on 
interven2ons 
to 
incorporate 
their 
impact 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
17
Long-­‐term 
Opera2onal 
Es2mates 
• Based 
on 
forced 
bend 
through 
extreme 
reduc2on 
in 
transmission 
coefficients, 
no 
evidence 
to 
support 
bends 
at 
these 
points 
– Long 
DRAFT 
term 
– 
projecNot 
2ons 
are 
for 
unstable 
a.ribu2on 
or 
distribu2on 
18 
Turn 
from 
8-­‐26 
End 
from 
8-­‐26 
Total 
Case 
EsHmate 
1 
month 
6 
months 
15,800 
1 
month 
18 
months 
31,300 
3 
months 
6 
months 
64,300 
3 
months 
18 
months 
120,000 
6 
months 
9 
months 
599,000 
6 
months 
18 
months 
857,000
Next 
Steps 
• Detailed 
HCW 
infec2on 
analysis 
underway 
– Looking 
at 
exposure 
and 
infec2ons 
in 
Liberia 
to 
assess 
the 
a.ri2on 
rates 
of 
HCW 
under 
current 
condi2ons 
• Ini2al 
version 
of 
Sierra 
Leone 
constructed 
– Ini2al 
look 
at 
subloca2on 
modeling 
required 
a 
re-­‐ 
adjustment 
– Should 
start 
simula2ons 
this 
week 
• Build 
similar 
versions 
for 
other 
affected 
countries 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
19
Next 
steps 
• Publica2ons 
– One 
submi.ed, 
another 
in 
the 
works 
– 2 
quick 
communica2ons 
in 
prep 
• Problems 
appropriate 
for 
agent-­‐based 
approach 
– Logis2cal 
ques2ons 
surrounding 
delivery 
and 
use 
of 
medical 
supplies 
– Effects 
of 
limited 
HCW 
both 
direct 
and 
indirect 
– Synthe2c 
outbreaks 
to 
compare 
to 
what 
we’ve 
observed 
of 
this 
one, 
to 
es2mate 
true 
size 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
20
Suppor2ng 
material 
describing 
model 
structure, 
and 
previous 
results 
APPENDIX 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
21
Legrand 
et 
al. 
Model 
Descrip2on 
Susceptible 
Exposed 
not infectious 
Infectious 
Symptomatic 
Hospitalized 
Infectious 
Funeral 
Infectious 
Removed 
Recovered and immune 
or dead and buried 
Legrand, 
J, 
R 
F 
Grais, 
P 
Y 
Boelle, 
A 
J 
Valleron, 
and 
A 
Flahault. 
“Understanding 
the 
Dynamics 
of 
Ebola 
Epidemics” 
Epidemiology 
and 
Infec1on 
135 
(4). 
2007. 
Cambridge 
University 
Press: 
610–21. 
doi:10.1017/S0950268806007217. 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
22
Compartmental 
Model 
• Extension 
of 
model 
proposed 
by 
Legrand 
et 
al. 
Legrand, 
J, 
R 
F 
Grais, 
P 
Y 
Boelle, 
A 
J 
Valleron, 
and 
A 
Flahault. 
“Understanding 
the 
Dynamics 
of 
Ebola 
Epidemics” 
Epidemiology 
and 
Infec1on 
135 
(4). 
2007. 
Cambridge 
University 
Press: 
610–21. 
doi:10.1017/S0950268806007217. 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
23
Legrand 
et 
al. 
Approach 
• Behavioral 
changes 
to 
reduce 
transmissibili2es 
at 
specified 
days 
• Stochas2c 
implementa2on 
fit 
to 
two 
historical 
outbreaks 
– Kikwit, 
DRC, 
1995 
– Gulu, 
Uganda, 
2000 
• Finds 
two 
different 
“types” 
of 
outbreaks 
– Community 
vs. 
Funeral 
driven 
outbreaks 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
24
Parameters 
of 
two 
historical 
outbreaks 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
25
NDSSL 
Extensions 
to 
Legrand 
Model 
• Mul2ple 
stages 
of 
behavioral 
change 
possible 
during 
this 
prolonged 
outbreak 
• Op2miza2on 
of 
fit 
through 
automated 
method 
• Experiment: 
– Explore 
“degree” 
of 
fit 
using 
the 
two 
different 
outbreak 
types 
for 
each 
country 
in 
current 
outbreak 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
26
Op2mized 
Fit 
Process 
• Parameters 
to 
explored 
selected 
– Diag_rate, 
beta_I, 
beta_H, 
beta_F, 
gamma_I, 
gamma_D, 
gamma_F, 
gamma_H 
– Ini2al 
values 
based 
on 
two 
historical 
outbreak 
• Op2miza2on 
rou2ne 
– Runs 
model 
with 
various 
permuta2ons 
of 
parameters 
– Output 
compared 
to 
observed 
case 
count 
– Algorithm 
chooses 
combina2ons 
that 
minimize 
the 
difference 
between 
observed 
case 
counts 
and 
model 
outputs, 
selects 
“best” 
one 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
27
Fi.ed 
Model 
Caveats 
• Assump2ons: 
– Behavioral 
changes 
effect 
each 
transmission 
route 
similarly 
– Mixing 
occurs 
differently 
for 
each 
of 
the 
three 
compartments 
but 
uniformly 
within 
• These 
models 
are 
likely 
“overfi.ed” 
– Many 
combos 
of 
parameters 
will 
fit 
the 
same 
curve 
– Guided 
by 
knowledge 
of 
the 
outbreak 
and 
addi2onal 
data 
sources 
to 
keep 
parameters 
plausible 
– Structure 
of 
the 
model 
is 
supported 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
28
No2onal 
US 
es2mates 
Approach 
• Get 
disease 
parameters 
from 
fi.ed 
model 
in 
West 
Africa 
• Put 
into 
CNIMS 
plauorm 
– ISIS 
simula2on 
GUI 
– Modify 
to 
represent 
US 
• Example 
Experiment: 
– 100 
replicates 
– One 
case 
introduc2on 
into 
Washington 
DC 
– Simulate 
for 
3 
weeks 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
29
No2onal 
US 
es2mates 
Assump2ons 
• Under 
assump2on 
that 
Ebola 
case, 
arrives 
and 
doesn’t 
seek 
care 
and 
avoids 
detec2on 
throughout 
illness 
• CNIMS 
based 
simula2ons 
– Agent-­‐based 
models 
of 
popula2ons 
with 
realis2c 
social 
networks, 
built 
up 
from 
high 
resolu2on 
census, 
ac2vity, 
and 
loca2on 
data 
• Assume: 
– Transmission 
calibrated 
to 
R0 
of 
3.5 
if 
transmission 
is 
like 
flu 
– Reduced 
transmission 
Ebola 
70% 
less 
likely 
to 
infect 
in 
home 
and 
95% 
less 
likely 
to 
infect 
outside 
of 
home 
than 
respiratory 
illness 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
30
No2onal 
US 
es2mates 
Example 
An Epi Plot 
Cell=7187 
Replicate Mean 
Overall Mean 
0 5 10 15 20 
0 1 2 3 4 5 6 
Cumulative Infections 
100 
replicates 
Day 
Mean 
of 
1.8 
cases 
Max 
of 
6 
cases 
Majority 
only 
one 
ini2al 
case 
DRAFT 
– 
Not 
for 
a.ribu2on 
or 
distribu2on 
31

More Related Content

What's hot

Modeling the Ebola Outbreak in West Africa, November 7th 2014 update
Modeling the Ebola Outbreak in West Africa, November 7th 2014 updateModeling the Ebola Outbreak in West Africa, November 7th 2014 update
Modeling the Ebola Outbreak in West Africa, November 7th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, September 30th 2014 update
Modeling the Ebola Outbreak in West Africa, September 30th 2014 updateModeling the Ebola Outbreak in West Africa, September 30th 2014 update
Modeling the Ebola Outbreak in West Africa, September 30th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, September 16th 2014 update
Modeling the Ebola Outbreak in West Africa, September 16th 2014 updateModeling the Ebola Outbreak in West Africa, September 16th 2014 update
Modeling the Ebola Outbreak in West Africa, September 16th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, March 10th 2015 update
Modeling the Ebola Outbreak in West Africa, March 10th 2015 updateModeling the Ebola Outbreak in West Africa, March 10th 2015 update
Modeling the Ebola Outbreak in West Africa, March 10th 2015 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, February 3rd 2015 update
Modeling the Ebola Outbreak in West Africa, February 3rd 2015 updateModeling the Ebola Outbreak in West Africa, February 3rd 2015 update
Modeling the Ebola Outbreak in West Africa, February 3rd 2015 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, October 7th 2014 update
Modeling the Ebola Outbreak in West Africa, October 7th 2014 updateModeling the Ebola Outbreak in West Africa, October 7th 2014 update
Modeling the Ebola Outbreak in West Africa, October 7th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, December 16th 2014 update
Modeling the Ebola Outbreak in West Africa, December 16th 2014 updateModeling the Ebola Outbreak in West Africa, December 16th 2014 update
Modeling the Ebola Outbreak in West Africa, December 16th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa January 6th 2015 update
Modeling the Ebola Outbreak in West Africa January 6th 2015 updateModeling the Ebola Outbreak in West Africa January 6th 2015 update
Modeling the Ebola Outbreak in West Africa January 6th 2015 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, November 25th 2014 update
Modeling the Ebola Outbreak in West Africa, November 25th 2014 updateModeling the Ebola Outbreak in West Africa, November 25th 2014 update
Modeling the Ebola Outbreak in West Africa, November 25th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, February 24th 2015 update
Modeling the Ebola Outbreak in West Africa, February 24th 2015 updateModeling the Ebola Outbreak in West Africa, February 24th 2015 update
Modeling the Ebola Outbreak in West Africa, February 24th 2015 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, October 21st 2014 update
Modeling the Ebola Outbreak in West Africa, October 21st 2014 updateModeling the Ebola Outbreak in West Africa, October 21st 2014 update
Modeling the Ebola Outbreak in West Africa, October 21st 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, January 20th 2015 update
Modeling the Ebola Outbreak in West Africa, January 20th 2015 updateModeling the Ebola Outbreak in West Africa, January 20th 2015 update
Modeling the Ebola Outbreak in West Africa, January 20th 2015 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, December 22nd 2014 update
Modeling the Ebola Outbreak in West Africa, December 22nd 2014 updateModeling the Ebola Outbreak in West Africa, December 22nd 2014 update
Modeling the Ebola Outbreak in West Africa, December 22nd 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, January 13th 2015 update
Modeling the Ebola Outbreak in West Africa, January 13th 2015 updateModeling the Ebola Outbreak in West Africa, January 13th 2015 update
Modeling the Ebola Outbreak in West Africa, January 13th 2015 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, October 15th 2014 update
Modeling the Ebola Outbreak in West Africa, October 15th 2014 updateModeling the Ebola Outbreak in West Africa, October 15th 2014 update
Modeling the Ebola Outbreak in West Africa, October 15th 2014 update
Biocomplexity Institute of Virginia Tech
 
Modeling the Ebola Outbreak in West Africa, September 23rd 2014 update
Modeling the Ebola Outbreak in West Africa, September 23rd 2014 updateModeling the Ebola Outbreak in West Africa, September 23rd 2014 update
Modeling the Ebola Outbreak in West Africa, September 23rd 2014 update
Biocomplexity Institute of Virginia Tech
 
Interepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, Kenya
Interepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, KenyaInterepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, Kenya
Interepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, Kenya
Mark Nanyingi
 

What's hot (20)

Modeling the Ebola Outbreak in West Africa, November 7th 2014 update
Modeling the Ebola Outbreak in West Africa, November 7th 2014 updateModeling the Ebola Outbreak in West Africa, November 7th 2014 update
Modeling the Ebola Outbreak in West Africa, November 7th 2014 update
 
Modeling the Ebola Outbreak in West Africa, September 30th 2014 update
Modeling the Ebola Outbreak in West Africa, September 30th 2014 updateModeling the Ebola Outbreak in West Africa, September 30th 2014 update
Modeling the Ebola Outbreak in West Africa, September 30th 2014 update
 
Modeling the Ebola Outbreak in West Africa, September 16th 2014 update
Modeling the Ebola Outbreak in West Africa, September 16th 2014 updateModeling the Ebola Outbreak in West Africa, September 16th 2014 update
Modeling the Ebola Outbreak in West Africa, September 16th 2014 update
 
Modeling the Ebola Outbreak in West Africa, March 10th 2015 update
Modeling the Ebola Outbreak in West Africa, March 10th 2015 updateModeling the Ebola Outbreak in West Africa, March 10th 2015 update
Modeling the Ebola Outbreak in West Africa, March 10th 2015 update
 
Modeling the Ebola Outbreak in West Africa, August 11th 2014 update
Modeling the Ebola Outbreak in West Africa, August 11th 2014 updateModeling the Ebola Outbreak in West Africa, August 11th 2014 update
Modeling the Ebola Outbreak in West Africa, August 11th 2014 update
 
Modeling the Ebola Outbreak in West Africa, February 3rd 2015 update
Modeling the Ebola Outbreak in West Africa, February 3rd 2015 updateModeling the Ebola Outbreak in West Africa, February 3rd 2015 update
Modeling the Ebola Outbreak in West Africa, February 3rd 2015 update
 
Modeling the Ebola Outbreak in West Africa, August 4th 2014 update
Modeling the Ebola Outbreak in West Africa, August 4th 2014 updateModeling the Ebola Outbreak in West Africa, August 4th 2014 update
Modeling the Ebola Outbreak in West Africa, August 4th 2014 update
 
Modeling the Ebola Outbreak in West Africa, October 7th 2014 update
Modeling the Ebola Outbreak in West Africa, October 7th 2014 updateModeling the Ebola Outbreak in West Africa, October 7th 2014 update
Modeling the Ebola Outbreak in West Africa, October 7th 2014 update
 
Modeling the Ebola Outbreak in West Africa, December 16th 2014 update
Modeling the Ebola Outbreak in West Africa, December 16th 2014 updateModeling the Ebola Outbreak in West Africa, December 16th 2014 update
Modeling the Ebola Outbreak in West Africa, December 16th 2014 update
 
Modeling the Ebola Outbreak in West Africa January 6th 2015 update
Modeling the Ebola Outbreak in West Africa January 6th 2015 updateModeling the Ebola Outbreak in West Africa January 6th 2015 update
Modeling the Ebola Outbreak in West Africa January 6th 2015 update
 
Modeling the Ebola Outbreak in West Africa, November 25th 2014 update
Modeling the Ebola Outbreak in West Africa, November 25th 2014 updateModeling the Ebola Outbreak in West Africa, November 25th 2014 update
Modeling the Ebola Outbreak in West Africa, November 25th 2014 update
 
Modeling the Ebola Outbreak in West Africa, February 24th 2015 update
Modeling the Ebola Outbreak in West Africa, February 24th 2015 updateModeling the Ebola Outbreak in West Africa, February 24th 2015 update
Modeling the Ebola Outbreak in West Africa, February 24th 2015 update
 
Modeling the Ebola Outbreak in West Africa, August 19th 2014 update
Modeling the Ebola Outbreak in West Africa, August 19th 2014 updateModeling the Ebola Outbreak in West Africa, August 19th 2014 update
Modeling the Ebola Outbreak in West Africa, August 19th 2014 update
 
Modeling the Ebola Outbreak in West Africa, October 21st 2014 update
Modeling the Ebola Outbreak in West Africa, October 21st 2014 updateModeling the Ebola Outbreak in West Africa, October 21st 2014 update
Modeling the Ebola Outbreak in West Africa, October 21st 2014 update
 
Modeling the Ebola Outbreak in West Africa, January 20th 2015 update
Modeling the Ebola Outbreak in West Africa, January 20th 2015 updateModeling the Ebola Outbreak in West Africa, January 20th 2015 update
Modeling the Ebola Outbreak in West Africa, January 20th 2015 update
 
Modeling the Ebola Outbreak in West Africa, December 22nd 2014 update
Modeling the Ebola Outbreak in West Africa, December 22nd 2014 updateModeling the Ebola Outbreak in West Africa, December 22nd 2014 update
Modeling the Ebola Outbreak in West Africa, December 22nd 2014 update
 
Modeling the Ebola Outbreak in West Africa, January 13th 2015 update
Modeling the Ebola Outbreak in West Africa, January 13th 2015 updateModeling the Ebola Outbreak in West Africa, January 13th 2015 update
Modeling the Ebola Outbreak in West Africa, January 13th 2015 update
 
Modeling the Ebola Outbreak in West Africa, October 15th 2014 update
Modeling the Ebola Outbreak in West Africa, October 15th 2014 updateModeling the Ebola Outbreak in West Africa, October 15th 2014 update
Modeling the Ebola Outbreak in West Africa, October 15th 2014 update
 
Modeling the Ebola Outbreak in West Africa, September 23rd 2014 update
Modeling the Ebola Outbreak in West Africa, September 23rd 2014 updateModeling the Ebola Outbreak in West Africa, September 23rd 2014 update
Modeling the Ebola Outbreak in West Africa, September 23rd 2014 update
 
Interepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, Kenya
Interepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, KenyaInterepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, Kenya
Interepidemic Seroepidemiological Survey of Rift Valley Fever in Garissa, Kenya
 

Similar to Modeling the Ebola Outbreak in West Africa, September 2nd 2014 update

Modeling the Ebola Outbreak in West Africa, November 18th 2014 update
Modeling the Ebola Outbreak in West Africa, November 18th 2014 updateModeling the Ebola Outbreak in West Africa, November 18th 2014 update
Modeling the Ebola Outbreak in West Africa, November 18th 2014 update
Biocomplexity Institute of Virginia Tech
 
GLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATIONGLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATION
Preetam Kar
 
SA’s COVID-19 Epidemic: Trends & Next steps
SA’s COVID-19 Epidemic: Trends & Next stepsSA’s COVID-19 Epidemic: Trends & Next steps
SA’s COVID-19 Epidemic: Trends & Next steps
SABC News
 
SA’s Covid-19 epidemic: Trends & Next steps
SA’s Covid-19 epidemic: Trends & Next stepsSA’s Covid-19 epidemic: Trends & Next steps
SA’s Covid-19 epidemic: Trends & Next steps
SABC News
 
Zika Virus Surveillance and Reporting in the Caribbean
Zika Virus Surveillance and Reporting in the CaribbeanZika Virus Surveillance and Reporting in the Caribbean
Zika Virus Surveillance and Reporting in the Caribbean
UWI_Markcomm
 
Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014
Tim Inglis
 
M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...
M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...
M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...
EuFMD
 
Ipv a new perspective in polio prevention
Ipv  a new perspective in polio preventionIpv  a new perspective in polio prevention
Ipv a new perspective in polio prevention
Rajagopalan Ramkumar
 
National Vector Borne Disease Control Program.pptx
National Vector Borne Disease Control Program.pptxNational Vector Borne Disease Control Program.pptx
National Vector Borne Disease Control Program.pptx
DR.SUMIT SABLE
 
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment Guidelines
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment GuidelinesAIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment Guidelines
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment Guidelines
AIDSTAROne
 
Mitigation of the impacts of Rift Valley fever through targeted vaccination s...
Mitigation of the impacts of Rift Valley fever through targeted vaccination s...Mitigation of the impacts of Rift Valley fever through targeted vaccination s...
Mitigation of the impacts of Rift Valley fever through targeted vaccination s...
ILRI
 
Polio Outbreak SOP Introduction
Polio Outbreak SOP IntroductionPolio Outbreak SOP Introduction
Polio Outbreak SOP Introduction
aschharwood
 

Similar to Modeling the Ebola Outbreak in West Africa, September 2nd 2014 update (13)

Modeling the Ebola Outbreak in West Africa, November 18th 2014 update
Modeling the Ebola Outbreak in West Africa, November 18th 2014 updateModeling the Ebola Outbreak in West Africa, November 18th 2014 update
Modeling the Ebola Outbreak in West Africa, November 18th 2014 update
 
Reflection From My Desk Review of Liberia's Public Health System
Reflection From My Desk Review of Liberia's Public Health SystemReflection From My Desk Review of Liberia's Public Health System
Reflection From My Desk Review of Liberia's Public Health System
 
GLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATIONGLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATION
 
SA’s COVID-19 Epidemic: Trends & Next steps
SA’s COVID-19 Epidemic: Trends & Next stepsSA’s COVID-19 Epidemic: Trends & Next steps
SA’s COVID-19 Epidemic: Trends & Next steps
 
SA’s Covid-19 epidemic: Trends & Next steps
SA’s Covid-19 epidemic: Trends & Next stepsSA’s Covid-19 epidemic: Trends & Next steps
SA’s Covid-19 epidemic: Trends & Next steps
 
Zika Virus Surveillance and Reporting in the Caribbean
Zika Virus Surveillance and Reporting in the CaribbeanZika Virus Surveillance and Reporting in the Caribbean
Zika Virus Surveillance and Reporting in the Caribbean
 
Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014Ebola Virus Disease outbreak, 2014
Ebola Virus Disease outbreak, 2014
 
M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...
M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...
M. Tildeslay - Real-time decision making - Appropriate use of infectious dise...
 
Ipv a new perspective in polio prevention
Ipv  a new perspective in polio preventionIpv  a new perspective in polio prevention
Ipv a new perspective in polio prevention
 
National Vector Borne Disease Control Program.pptx
National Vector Borne Disease Control Program.pptxNational Vector Borne Disease Control Program.pptx
National Vector Borne Disease Control Program.pptx
 
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment Guidelines
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment GuidelinesAIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment Guidelines
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment Guidelines
 
Mitigation of the impacts of Rift Valley fever through targeted vaccination s...
Mitigation of the impacts of Rift Valley fever through targeted vaccination s...Mitigation of the impacts of Rift Valley fever through targeted vaccination s...
Mitigation of the impacts of Rift Valley fever through targeted vaccination s...
 
Polio Outbreak SOP Introduction
Polio Outbreak SOP IntroductionPolio Outbreak SOP Introduction
Polio Outbreak SOP Introduction
 

More from Biocomplexity Institute of Virginia Tech

Ebola response in Liberia: A step towards real-time epidemic science
Ebola response in Liberia: A step towards real-time epidemic scienceEbola response in Liberia: A step towards real-time epidemic science
Ebola response in Liberia: A step towards real-time epidemic science
Biocomplexity Institute of Virginia Tech
 
Use of CINET in Education and Research
Use of CINET in Education and ResearchUse of CINET in Education and Research
Use of CINET in Education and Research
Biocomplexity Institute of Virginia Tech
 
Using CINET
Using CINETUsing CINET
CINET: A Cyber-Infrastructure for Network Science Overview
CINET: A Cyber-Infrastructure for Network Science OverviewCINET: A Cyber-Infrastructure for Network Science Overview
CINET: A Cyber-Infrastructure for Network Science Overview
Biocomplexity Institute of Virginia Tech
 
Network Science: Theory, Modeling and Applications
Network Science: Theory, Modeling and ApplicationsNetwork Science: Theory, Modeling and Applications
Network Science: Theory, Modeling and Applications
Biocomplexity Institute of Virginia Tech
 

More from Biocomplexity Institute of Virginia Tech (6)

Ebola response in Liberia: A step towards real-time epidemic science
Ebola response in Liberia: A step towards real-time epidemic scienceEbola response in Liberia: A step towards real-time epidemic science
Ebola response in Liberia: A step towards real-time epidemic science
 
Use of CINET in Education and Research
Use of CINET in Education and ResearchUse of CINET in Education and Research
Use of CINET in Education and Research
 
Using CINET
Using CINETUsing CINET
Using CINET
 
CINET: A Cyber-Infrastructure for Network Science Overview
CINET: A Cyber-Infrastructure for Network Science OverviewCINET: A Cyber-Infrastructure for Network Science Overview
CINET: A Cyber-Infrastructure for Network Science Overview
 
CINET: A CyberInfrastructure for Network Science
CINET: A CyberInfrastructure for Network ScienceCINET: A CyberInfrastructure for Network Science
CINET: A CyberInfrastructure for Network Science
 
Network Science: Theory, Modeling and Applications
Network Science: Theory, Modeling and ApplicationsNetwork Science: Theory, Modeling and Applications
Network Science: Theory, Modeling and Applications
 

Recently uploaded

In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
IvanMallco1
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
aishnasrivastava
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 

Recently uploaded (20)

In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 

Modeling the Ebola Outbreak in West Africa, September 2nd 2014 update

  • 1. Modeling the Ebola Outbreak in West Africa, 2014 Sept 2nd Update Bryan Lewis PhD, MPH (blewis@vbi.vt.edu) Caitlin Rivers MPH, Eric Lofgren PhD, James Schli., Ka2e Dunphy, Stephen Eubank PhD, Madhav Marathe PhD, and Chris Barre. PhD Technical Report #14-­‐099 DRAFT – Not for a.ribu2on or distribu2on
  • 2. Currently Used WHO Data Cases Deaths Guinea 648 430 Liberia 1378 694 Sierra Leone 1026 422 Nigeria 17 6 Total 3069 1563 ● Data reported by WHO on Aug 29 for cases as of Aug 26 ● Sierra Leone case counts censored up to 4/30/14. ● Time series was filled in with missing dates, and case counts were interpolated. DRAFT – Not for a.ribu2on or distribu2on 2
  • 3. Epi Notes • Case iden2fied in Senegal – Guinean student, sought care in Dakar, iden2fied and quaran2ned though did not report exposure to Ebola, thus HCWs were exposed. BBC • Liberian HCWs survival credited to Zmapp – Dr. Senga Omeonga and physician assistant Kynda Kobbah were discharged from a Liberian treatment center on Saturday ader recovering from the virus, according to the World Health Organiza2on. CNN DRAFT – Not for a.ribu2on or distribu2on 3
  • 4. Epi Notes • Guinea riot in Nzerekore (2nd city) on Aug 29 – Market area “disinfected,” angry residents a.ack HCW and hospital, “Ebola is a lie” BBC • India quaran2nes 6 “high-­‐risk” Ebola suspects on Monday in New Delhi – Among 181 passengers who arrived in India from the affected western African countries HealthMap DRAFT – Not for a.ribu2on or distribu2on 4
  • 5. Further evidence of endemic Ebola DRAFT – Not for a.ribu2on or distribu2on 5 • 1985 manuscript finds ~13% sero-­‐prevalence of Ebola in remote Liberia – Paired control study: Half from epilepsy pa2ents and half from healthy volunteers – Geographic and social group sub-­‐analysis shows all affected ~equally
  • 6. Twi.er Tracking DRAFT – Not for a.ribu2on or distribu2on 6 Most common images: Risk map, lab work (britain), joke cartoon, EBV rally
  • 7. Liberia Forecasts DRAFT – Not for a.ribu2on or distribu2on 7
  • 8. Liberia Forecasts rI: 0.95 rH: 0.65 rF: 0.61 R0 total: 2.22 DRAFT – Not for a.ribu2on or distribu2on 8 8/6 – 8/12 8/13 – 8/19 8/20 – 8/26 8/27 – 9/02 9/3 – 9/9 9/10 – 9/16 Actual 163 232 296 296 -­‐-­‐ -­‐-­‐ Forecast 133 176 234 310 410 543 Model Parameters 'alpha':1/12, 'beta_I':0.17950, 'beta_H':0.062036, 'beta_F':0.489256, 'gamma_h':0.308899, 'gamma_d':0.075121, 'gamma_I':0.050000, 'gamma_f':0.496443, 'delta_1':.5, 'delta_2':.5, 'dx':0.510845
  • 9. Liberia Vaccina2ons DRAFT – Not for a.ribu2on or distribu2on 9 20% of popula2on Vaccinated on Nov 1st and Jan 1st Addi2onal Infec2ons Prevented (by April 2015): Nov 1st -­‐ ~275k Jan 1st -­‐ ~225k
  • 10. New model for Liberia • Due to con2nued underes2ma2on, have refit model – Small increases in betas change the fit compared to “stable” fit of last 3 weeks – May shid to this model for future forecasts DRAFT – Not for a.ribu2on or distribu2on 10
  • 11. Sierra Leone Epi Details • asdfsdf DRAFT – Not for a.ribu2on or distribu2on 11 By Sierra Leone MoH has 1077 cases (vs. 1026 as reported by WHO)
  • 12. Sierra Leone Forecasts DRAFT – Not for a.ribu2on or distribu2on 12
  • 13. Sierra Leone Forecasts rI:0.85 rH:0.74 rF:0.31 R0 total: 1.90 DRAFT – Not for a.ribu2on or distribu2on 13 8/6 – 8/12 8/13 – 8/19 8/20 – 8/26 8/27 – 9/02 9/3 – 9/9 9/10 – 9/16 Actual 143 93 100 -­‐-­‐ -­‐-­‐ -­‐-­‐ Forecast 135 168 209 260 324 405 Model Parameters 'alpha':1/10 'beta_I':0.164121 'beta_H':0.048990 'beta_F':.16 'gamma_h':0.296 'gamma_d':0.044827 'gamma_I':0.055 'gamma_f':0.25 'delta_1':.55 delta_2':.55 'dx':0.58
  • 14. Sierra Leone Vaccina2ons DRAFT – Not for a.ribu2on or distribu2on 14 100k on Nov 1st 200k on Jan 1st Addi2onal Infec2ons prevented (by April 2015) Nov 1st -­‐ ~6k Jan 1st -­‐ ~7.5k
  • 15. All Countries Forecasts DRAFT – Not for a.ribu2on or distribu2on 15 rI:0.85 rH:0.74 rF:0.31 Overal:1.90
  • 16. All Countries Vaccina2ons DRAFT – Not for a.ribu2on or distribu2on 16 100k on Nov 1st 200k on Jan 1st Addi2onal Infec2ons prevented (by April 2015) Nov 1st -­‐ ~3.2k Jan 1st -­‐ ~4.0k • Need more than just vaccine to interupt transmission
  • 17. Extrac2ng the Guinea experience • Result: Not enough informa2on in early slight decrease to harvest meaningful impacts. – Model won’t fit well • Conclusion: Likely need to wait another week or so to assess impacts of recent new push on interven2ons to incorporate their impact DRAFT – Not for a.ribu2on or distribu2on 17
  • 18. Long-­‐term Opera2onal Es2mates • Based on forced bend through extreme reduc2on in transmission coefficients, no evidence to support bends at these points – Long DRAFT term – projecNot 2ons are for unstable a.ribu2on or distribu2on 18 Turn from 8-­‐26 End from 8-­‐26 Total Case EsHmate 1 month 6 months 15,800 1 month 18 months 31,300 3 months 6 months 64,300 3 months 18 months 120,000 6 months 9 months 599,000 6 months 18 months 857,000
  • 19. Next Steps • Detailed HCW infec2on analysis underway – Looking at exposure and infec2ons in Liberia to assess the a.ri2on rates of HCW under current condi2ons • Ini2al version of Sierra Leone constructed – Ini2al look at subloca2on modeling required a re-­‐ adjustment – Should start simula2ons this week • Build similar versions for other affected countries DRAFT – Not for a.ribu2on or distribu2on 19
  • 20. Next steps • Publica2ons – One submi.ed, another in the works – 2 quick communica2ons in prep • Problems appropriate for agent-­‐based approach – Logis2cal ques2ons surrounding delivery and use of medical supplies – Effects of limited HCW both direct and indirect – Synthe2c outbreaks to compare to what we’ve observed of this one, to es2mate true size DRAFT – Not for a.ribu2on or distribu2on 20
  • 21. Suppor2ng material describing model structure, and previous results APPENDIX DRAFT – Not for a.ribu2on or distribu2on 21
  • 22. Legrand et al. Model Descrip2on Susceptible Exposed not infectious Infectious Symptomatic Hospitalized Infectious Funeral Infectious Removed Recovered and immune or dead and buried Legrand, J, R F Grais, P Y Boelle, A J Valleron, and A Flahault. “Understanding the Dynamics of Ebola Epidemics” Epidemiology and Infec1on 135 (4). 2007. Cambridge University Press: 610–21. doi:10.1017/S0950268806007217. DRAFT – Not for a.ribu2on or distribu2on 22
  • 23. Compartmental Model • Extension of model proposed by Legrand et al. Legrand, J, R F Grais, P Y Boelle, A J Valleron, and A Flahault. “Understanding the Dynamics of Ebola Epidemics” Epidemiology and Infec1on 135 (4). 2007. Cambridge University Press: 610–21. doi:10.1017/S0950268806007217. DRAFT – Not for a.ribu2on or distribu2on 23
  • 24. Legrand et al. Approach • Behavioral changes to reduce transmissibili2es at specified days • Stochas2c implementa2on fit to two historical outbreaks – Kikwit, DRC, 1995 – Gulu, Uganda, 2000 • Finds two different “types” of outbreaks – Community vs. Funeral driven outbreaks DRAFT – Not for a.ribu2on or distribu2on 24
  • 25. Parameters of two historical outbreaks DRAFT – Not for a.ribu2on or distribu2on 25
  • 26. NDSSL Extensions to Legrand Model • Mul2ple stages of behavioral change possible during this prolonged outbreak • Op2miza2on of fit through automated method • Experiment: – Explore “degree” of fit using the two different outbreak types for each country in current outbreak DRAFT – Not for a.ribu2on or distribu2on 26
  • 27. Op2mized Fit Process • Parameters to explored selected – Diag_rate, beta_I, beta_H, beta_F, gamma_I, gamma_D, gamma_F, gamma_H – Ini2al values based on two historical outbreak • Op2miza2on rou2ne – Runs model with various permuta2ons of parameters – Output compared to observed case count – Algorithm chooses combina2ons that minimize the difference between observed case counts and model outputs, selects “best” one DRAFT – Not for a.ribu2on or distribu2on 27
  • 28. Fi.ed Model Caveats • Assump2ons: – Behavioral changes effect each transmission route similarly – Mixing occurs differently for each of the three compartments but uniformly within • These models are likely “overfi.ed” – Many combos of parameters will fit the same curve – Guided by knowledge of the outbreak and addi2onal data sources to keep parameters plausible – Structure of the model is supported DRAFT – Not for a.ribu2on or distribu2on 28
  • 29. No2onal US es2mates Approach • Get disease parameters from fi.ed model in West Africa • Put into CNIMS plauorm – ISIS simula2on GUI – Modify to represent US • Example Experiment: – 100 replicates – One case introduc2on into Washington DC – Simulate for 3 weeks DRAFT – Not for a.ribu2on or distribu2on 29
  • 30. No2onal US es2mates Assump2ons • Under assump2on that Ebola case, arrives and doesn’t seek care and avoids detec2on throughout illness • CNIMS based simula2ons – Agent-­‐based models of popula2ons with realis2c social networks, built up from high resolu2on census, ac2vity, and loca2on data • Assume: – Transmission calibrated to R0 of 3.5 if transmission is like flu – Reduced transmission Ebola 70% less likely to infect in home and 95% less likely to infect outside of home than respiratory illness DRAFT – Not for a.ribu2on or distribu2on 30
  • 31. No2onal US es2mates Example An Epi Plot Cell=7187 Replicate Mean Overall Mean 0 5 10 15 20 0 1 2 3 4 5 6 Cumulative Infections 100 replicates Day Mean of 1.8 cases Max of 6 cases Majority only one ini2al case DRAFT – Not for a.ribu2on or distribu2on 31